Literature DB >> 22526869

Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study.

D A Barr1, L Semple, R A Seaton.   

Abstract

Despite increasing use, limited data has been published comparing safety of different outpatient parenteral antimicrobial therapy (OPAT) models. Potential risks of self-administration at home include venous access device infection and other line complications. This study aims to investigate rates and predictors of intravenous access device complications in a large OPAT cohort. This is a retrospective cohort study of all uses of midlines, peripherally inserted central catheters (PICCs) and tunnelled central venous catheters (TCVCs) with univariate and multivariate (logistic regression) analysis of factors associated with line infections (LIs) and with other line events (OLEs). On univariate analysis, line infections were associated with length of line use, female sex and TCVC lines (compared to midlines). Patients self-administering OPAT in the home had a non-significantly lower rate of LIs. On multivariate analysis only duration of line use was a significant predictor of LIs-OR 1.012 (95%CI 1.001-1.023). For OLEs, multivariate analysis suggested that only line type and use of flucloxacillin were significant explanatory variables. In this cohort, there is no evidence that self-administration of OPAT is associated with higher rates of venous access device complications after controlling for confounding variables.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526869     DOI: 10.1007/s10096-012-1604-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  The peripherally inserted central catheter (PICC): a prospective study of its natural history after cubital fossa insertion.

Authors:  M R Loewenthal; P M Dobson; R E Starkey; S A Dagg; A Petersen; M J Boyle
Journal:  Anaesth Intensive Care       Date:  2002-02       Impact factor: 1.669

2.  The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom.

Authors:  D Nathwani
Journal:  Chemotherapy       Date:  2001       Impact factor: 2.544

3.  Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.

Authors:  D A Barr; L Semple; R A Seaton
Journal:  Int J Antimicrob Agents       Date:  2012-03-23       Impact factor: 5.283

4.  Complications related to intravenous midline catheter usage. A 2-year study.

Authors:  A M Goetz; J Miller; M M Wagener; R R Muder
Journal:  J Intraven Nurs       Date:  1998 Mar-Apr

5.  Improving antibiotic treatment outcomes through the implementation of a midline: piloting a change in practice for cystic fibrosis patients.

Authors:  Melita Cummings; Neville Hearse; Helen McCutcheon; Kate Deuter
Journal:  J Vasc Nurs       Date:  2011-03

6.  Intravenous administration issues: a comparison of intravenous insertions and complications in vancomycin versus other antibiotics.

Authors:  Sheila Roszell; Carla Jones
Journal:  J Infus Nurs       Date:  2010 Mar-Apr

7.  Catheter outcomes in home infusion.

Authors:  Melissa Leone; L Rad Dillon
Journal:  J Infus Nurs       Date:  2008 Mar-Apr

8.  Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes.

Authors:  Matthew R Amodeo; Tamlin Clulow; John Lainchbury; David R Murdoch; Kate Gallagher; Amanda Dyer; Sarah L Metcalf; Alan D Pithie; Stephen T Chambers
Journal:  J Infect       Date:  2009-09-17       Impact factor: 6.072

9.  An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service.

Authors:  Mark Gilchrist; Bryony Dean Franklin; Jignesh P Patel
Journal:  J Antimicrob Chemother       Date:  2008-04-12       Impact factor: 5.790

10.  Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.

Authors:  Philippa C Matthews; Christopher P Conlon; Anthony R Berendt; Jill Kayley; Lorrayne Jefferies; Bridget L Atkins; Ivor Byren
Journal:  J Antimicrob Chemother       Date:  2007-06-11       Impact factor: 5.790

View more
  16 in total

1.  Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.

Authors:  A Vargas-Palacios; D M Meads; M Twiddy; C Czoski Murray; C Hulme; E D Mitchell; A Gregson; P Stanley; J Minton
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

2.  Outpatient parenteral antimicrobial therapy.

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  Antimicrobial Agents and Catheter Complications in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Kathryn Dzintars; Lisa A Gorski; Deborah Williams; Sara E Cosgrove
Journal:  Pharmacotherapy       Date:  2018-03-30       Impact factor: 4.705

4.  Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence.

Authors:  Eavan G Muldoon; David R Snydman; Elizabeth C Penland; Geneve M Allison
Journal:  Clin Infect Dis       Date:  2013-04-09       Impact factor: 9.079

5.  Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs.

Authors:  William O Hahn; Brian J Werth; Susan M Butler-Wu; Robert M Rakita
Journal:  Emerg Infect Dis       Date:  2016-11       Impact factor: 6.883

Review 6.  Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.

Authors:  E D Mitchell; C Czoski Murray; D Meads; J Minton; J Wright; M Twiddy
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

7.  Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient's perspective: a qualitative study.

Authors:  Marvin A H Berrevoets; Anke J M Oerlemans; Mirjam Tromp; Bart Jan Kullberg; Jaap Ten Oever; Jeroen A Schouten; Marlies E Hulscher
Journal:  BMJ Open       Date:  2018-11-12       Impact factor: 2.692

8.  Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy.

Authors:  Jonathan Underwood; Michael Marks; Steve Collins; Sarah Logan; Gabriele Pollara
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

Review 9.  Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.

Authors:  Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2019-08-26

10.  Outpatient Parenteral Therapy for Complicated Staphylococcus aureus Infections: A Snapshot of Processes and Outcomes in the Real World.

Authors:  Jennifer Townsend; Sara Keller; Martin Tibuakuu; Sameer Thakker; Bailey Webster; Maya Siegel; Kevin J Psoter; Omar Mansour; Trish M Perl
Journal:  Open Forum Infect Dis       Date:  2018-10-24       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.